Timo Blomster

4.4k total citations
11 papers, 280 citations indexed

About

Timo Blomster is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Timo Blomster has authored 11 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Timo Blomster's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (5 papers). Timo Blomster is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (5 papers). Timo Blomster collaborates with scholars based in Finland, Australia and Uganda. Timo Blomster's co-authors include Ritva Koskela, Pauliina Molander, Helena Kemppainen, Airi Jussila, Martti Färkkilâ, Taina Sipponen, Markku Nissinen, Juha Kuisma, Kaija‐Leena Kolho and Henna Rautiainen and has published in prestigious journals such as BMC Public Health, Inflammatory Bowel Diseases and Scandinavian Journal of Gastroenterology.

In The Last Decade

Timo Blomster

11 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timo Blomster Finland 6 232 216 125 50 23 11 280
Ritva Koskela Finland 9 326 1.4× 344 1.6× 152 1.2× 57 1.1× 63 2.7× 17 423
E Iglesias-Flores Spain 8 246 1.1× 188 0.9× 131 1.0× 72 1.4× 20 0.9× 23 320
P. L. Fain United States 2 306 1.3× 196 0.9× 137 1.1× 91 1.8× 23 1.0× 4 368
James Fulforth New Zealand 6 158 0.7× 191 0.9× 93 0.7× 33 0.7× 26 1.1× 15 266
Fabián Juliao Baños Colombia 5 164 0.7× 130 0.6× 81 0.6× 19 0.4× 20 0.9× 38 209
Margalida Calafat Spain 7 138 0.6× 112 0.5× 86 0.7× 43 0.9× 30 1.3× 27 226
Jean-Eric Labérenne France 2 235 1.0× 199 0.9× 108 0.9× 22 0.4× 18 0.8× 3 254
María Josefina Etchevers Spain 6 193 0.8× 158 0.7× 92 0.7× 13 0.3× 14 0.6× 10 218
Katarzyna Karolewska‐Bochenek Poland 9 137 0.6× 123 0.6× 58 0.5× 59 1.2× 29 1.3× 20 234
Nuria Maroto Spain 7 130 0.6× 124 0.6× 90 0.7× 28 0.6× 54 2.3× 19 210

Countries citing papers authored by Timo Blomster

Since Specialization
Citations

This map shows the geographic impact of Timo Blomster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Blomster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Blomster more than expected).

Fields of papers citing papers by Timo Blomster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Blomster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Blomster. The network helps show where Timo Blomster may publish in the future.

Co-authorship network of co-authors of Timo Blomster

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Blomster. A scholar is included among the top collaborators of Timo Blomster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Blomster. Timo Blomster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ylisaukko‐oja, Tero, Clas-Göran af Björkesten, Airi Jussila, et al.. (2024). Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment. Heliyon. 10(12). e32432–e32432. 1 indexed citations
2.
Blomster, Timo, Olli‐Pekka Koivurova, Ritva Koskela, et al.. (2024). Pregnancy period and early-life risk factors for inflammatory bowel disease: a Northern Finland birth cohort 1966 study. BMC Public Health. 24(1). 1038–1038. 2 indexed citations
3.
Koivurova, Olli‐Pekka, Ritva Koskela, Timo Blomster, et al.. (2021). Serological Biomarker Panel in Diagnosis of Atrophic Gastritis andHelicobacter pyloriInfection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel®Test. Anticancer Research. 41(11). 5527–5537. 19 indexed citations
4.
Koivurova, Olli‐Pekka, Olavi Ukkola, Tapani Ebeling, et al.. (2020). Screening of the Patients with Autoimmune Thyroid Disease (AITD) and Type 1 Diabetes Mellitus (DM1) for Atrophic Gastritis (AG) by Serological Biomarker Testing (GastroPanel. 7(9). 181–195. 7 indexed citations
5.
Ylisaukko‐oja, Tero, Jaakko Aaltonen, Timo Blomster, et al.. (2017). P515 Evaluation of treatment persistence of vedolizumab among Finnish inflammatory bowel disease patients in real-life clinical practice (FINVEDO). Journal of Crohn s and Colitis. 11(suppl_1). S342–S342. 1 indexed citations
6.
Molander, Pauliina, Martti Färkkilâ, Helena Kemppainen, et al.. (2016). Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents. Scandinavian Journal of Gastroenterology. 52(3). 284–290. 13 indexed citations
7.
Molander, Pauliina, Martti Färkkilâ, Ari Ristimäki, et al.. (2014). Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?. Journal of Crohn s and Colitis. 9(1). 33–40. 83 indexed citations
8.
Molander, Pauliina, Martti Färkkilâ, Kimmo Salminen, et al.. (2014). Outcome After Discontinuation of TNFα-blocking Therapy in Patients with Inflammatory Bowel Disease in Deep Remission. Inflammatory Bowel Diseases. 20(6). 1–1. 58 indexed citations
9.
Kantala, Tuija, Katri Jalava, Kirsi‐Maria Haapasaari, et al.. (2013). Suomalaismiehen kotoperäinen E-hepatiittitartunta. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 129(20). 2169–2173. 3 indexed citations
10.
Kuusi, Markku, Tuija Kantala, Leena Maunula, et al.. (2013). [A domestic human case of hepatitis E in Finland].. PubMed. 129(20). 2169–73. 5 indexed citations
11.
Molander, Pauliina, Taina Sipponen, Helena Kemppainen, et al.. (2012). Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD. Journal of Crohn s and Colitis. 7(9). 730–735. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ritva Koskela Breakdown of academic impact, for papers by E Iglesias-Flores Breakdown of academic impact, for papers by P. L. Fain Breakdown of academic impact, for papers by James Fulforth Breakdown of academic impact, for papers by Fabián Juliao Baños Breakdown of academic impact, for papers by Margalida Calafat Breakdown of academic impact, for papers by Jean-Eric Labérenne Breakdown of academic impact, for papers by María Josefina Etchevers Breakdown of academic impact, for papers by Katarzyna Karolewska‐Bochenek Breakdown of academic impact, for papers by Nuria Maroto
Rankless by CCL
2026